Alexis Borisy
CIK: 0001319446
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 18, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct1.2K shares- - Jun 11, 2026PBLS
Parabilis Medicines, Inc.
Conversion(C)Direct105.4K shares- - Jun 9, 2026PBLS
Parabilis Medicines, Inc.
Award(A)DirectStock Option (Right to Buy)
20.2K shares- - Jun 9, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
32.9K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Tender Offer(U)Direct74.2K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Disposition(D)Direct3.9K shares- - Jun 26, 2025RVMD
Revolution Medicines, Inc.
Award(A)Direct3.1K shares- - Jun 18, 2025BPMC
Blueprint Medicines Corp
Award(A)Direct3.9K shares at avg. $128.12$500K - Jun 6, 2025RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
136.7K shares- - Jun 5, 2025TNGX
Tango Therapeutics, Inc.
Award(A)Direct6.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  RVMD Revolution Medicines, Inc. | Award(A) | 1,191 | - | $0 | Direct |
| Jun 11, 2026 |  PBLS Parabilis Medicines, Inc. | Conversion(C) | 105,414 | - | $0 | Direct |
| Jun 9, 2026 | PBLS Parabilis Medicines, Inc. | Award(A) Stock Option (Right to Buy) | 20,215 | - | - | Direct |
| Jun 9, 2026 |  RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 32,947 | - | - | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Tender Offer(U) | 74,160 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Disposition(D) | 3,902 | - | - | Direct |
| Jun 26, 2025 | RVMD Revolution Medicines, Inc. | Award(A) | 3,142 | - | - | Direct |
| Jun 18, 2025 | BPMC Blueprint Medicines Corp | Award(A) | 3,902 | $128.12 | $499,924 | Direct |
| Jun 6, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 136,681 | - | - | Direct |
| Jun 5, 2025 |  TNGX Tango Therapeutics, Inc. | Award(A) | 6,250 | - | - | Direct |
1-10 of 10 transactions
About Borisy Alexis
Borisy Alexis (SEC CIK 0001319446) files insider reports with the SEC as Director of Revolution Medicines, Inc. (RVMD), Director of Parabilis Medicines, Inc. (PBLS) and Director of Relay Therapeutics, Inc. (RLAY). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 10 ownership filings by Borisy Alexis (1 Form 3, 9 Form 4), filed between Jun 6, 2025 and Jun 23, 2026. Those filings report 10 transactions, from Jun 5, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Borisy Alexis's filings is in CAMBRIDGE, MA.
Recent filings by Borisy Alexis
- Jun 18, 2026: Grant or award of RVMD shares (Form 4, code A).
- Jun 11, 2026: Conversion of PBLS shares (Form 4, code C).
- Jun 9, 2026: Grant or award of PBLS derivative securities (Form 4, code A).
- Jun 9, 2026: Grant or award of RLAY derivative securities (Form 4, code A).
- Jul 17, 2025: Tender of shares transaction of BPMC shares (Form 4, code U).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer